Keywords: ilex, pay, 140m, campath, rights, oncology, take

Ilex to pay $140M for Campath rights

Article | 31 October 2001

Print This

Ilex Oncology is to take over rights in the USA to the recently-approvedB-cell chronic lymphocytic leukemia drug Campath (alemtuzumab), after ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in